# Topotecan in Treating Children With Refractory Leukemia

> **NCT00002705** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 3 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00002705
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-04
- **Primary completion:** 2001-01
- **Final completion:** —
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2013-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002705, "Topotecan in Treating Children With Refractory Leukemia". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00002705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*